{"nct_id":"NCT05766501","title":"A Study of Doravirine/Islatravir (DOR/ISL, MK-8591A) for the Treatment of Human Immunodeficiency Virus 1 (HIV-1) Infection in Participants Who Previously Received DOR/ISL (MK-8591A-054)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2024-11","start_date":"2023-03-17","start_date_type":"ACTUAL","primary_completion_date":"2025-12-03","primary_completion_date_type":"ESTIMATED","completion_date":"2028-09-06","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["MRK"]}